TrialHaematologica2019

CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.

Evgeniya Angelova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.